New eye injection shows promise for Diabetes-Related vision loss
NCT ID NCT05301751
Summary
This study tested a new eye injection called AG-73305 in people with diabetic macular edema, a condition where diabetes causes fluid buildup in the eye that can damage vision. Researchers gave 25 participants different doses of the injection to check if it was safe and if it helped improve their vision over six months. The goal was to find the best dose for future studies and see if this treatment could help control this diabetes complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center of Macula and Retina Disease
Winter Haven, Florida, 33880, United States
-
Retina Research Institute of Texas
Abilene, Texas, 79606, United States
-
Retina Vitreous Associates of Florida
St. Petersburg, Florida, 33711, United States
-
Strategic Clinical Research Group, LLC
Willow Park, Texas, 76087, United States
-
Texas Retina Associates
Fort Worth, Texas, 76104, United States
-
Valley Retina Institute
McAllen, Texas, 78503, United States
Conditions
Explore the condition pages connected to this study.